Medication info

Urantak 100 mg (Ranitidine Hydrochloride)

Prescription medicationSolutionOral · Intramuscular injection · Intravenous injectionExpired
Ingredient · strength
Ranitidine Hydrochloride›112mg / 1 ampoule
Manufacturer / importer
Hanin Pharmaceutical Co., Ltd.
Appearance
A colorless to yellowish transparent solution or a brown ampoule form.
Packaging
1 ampoule (4 mL) × 50
Approval status
Expired

MFDS item code 198600664 · Notified 1986.12.13

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (ulcers, etc.), suppression of upper gastrointestinal bleeding, and prevention of Mendelson's syndrome
Who uses it
Adults · Children
Adult dosage
Adults Administer 50mg per dose of ranitidine 3-4 times daily by intravenous or intramuscular injection. For intravenous injection, dilute 50mg of this medicine in 20ml of normal saline or glucose injection and inject slowly over at least 2 minutes, or mix with an infusion solution and administer by intravenous infusion over 2 hours at a rate of 25mg/hr. In cases of upper gastrointestinal bleeding, an effect is generally observed within 1 week; switch to oral administration once it is possible to take the medicine orally. For premedication for anesthesia (prevention of Mendelson's syndrome), administer 50mg by intramuscular injection or inject slowly intravenously over 1 minute, 45-60 minutes before induction of anesthesia. Patients with renal impairment In patients with severe renal impairment and creatinine clearance of 50ml/min or less, reduce the dose to 25mg per dose, or extend the dosing interval and administer 50mg per dose every 18-24 hours. Depending on the patient's condition, 50mg may be administered every 12 hours. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Children's dosage
Clinical studies in children have not been established.

Ingredients

Manufacturer
Hanin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, etc.), suppression of upper gastrointestinal bleeding, and prevention of Mendelson's syndrome

  • Gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcer
  • peptic ulcer
  • acute stress ulcer
  • acute gastric mucosal lesions.
View approved original text

This medication is used to treat gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome prior to anesthesia and aids in the healing of ulcers after surgery. It is used to treat upper gastrointestinal bleeding, especially bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions. This medication is effective in improving gastrointestinal health and promoting wound healing.

Dosage and Administration

Adult dosage

Adults Administer 50mg per dose of ranitidine 3-4 times daily by intravenous or intramuscular injection. For intravenous injection, dilute 50mg of this medicine in 20ml of normal saline or glucose injection and inject slowly over at least 2 minutes, or mix with an infusion solution and administer by intravenous infusion over 2 hours at a rate of 25mg/hr. In cases of upper gastrointestinal bleeding, an effect is generally observed within 1 week; switch to oral administration once it is possible to take the medicine orally. For premedication for anesthesia (prevention of Mendelson's syndrome), administer 50mg by intramuscular injection or inject slowly intravenously over 1 minute, 45-60 minutes before induction of anesthesia. Patients with renal impairment In patients with severe renal impairment and creatinine clearance of 50ml/min or less, reduce the dose to 25mg per dose, or extend the dosing interval and administer 50mg per dose every 18-24 hours. Depending on the patient's condition, 50mg may be administered every 12 hours. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Children's dosage

Clinical studies in children have not been established.

Precautions

This medicine should not be used in patients with a history of allergic reactions to this medication or its components. Caution is required for patients with impaired kidney function as this medication may not be properly excreted, leading to increased blood concentration, thus dosage reduction or extended dosing intervals may be necessary. Patients with impaired liver function must also be particularly cautious when using this medication. Patients who have previously experienced drug allergic reactions or older adults should be administered this medicine carefully. Additionally, it is advisable to avoid this medication in patients with a history of the rare condition acute porphyria. When using this medication, careful observation of the patient's condition is necessary due to the potential for allergic reactions or serious side effects. If symptoms such as hives, rashes, difficulty breathing, or low blood pressure occur, discontinue use immediately and seek appropriate treatment. Blood-related side effects can rarely include leukopenia, thrombocytopenia, and anemia; therefore, tests should be conducted if symptoms such as fatigue, bleeding, or fever occur. If symptoms of liver dysfunction or jaundice arise, the use of this medication should be discontinued immediately. Heart-related side effects may rarely include bradycardia or arrhythmias, so patients with heart conditions should be particularly cautious. Gastrointestinal symptoms can rarely include constipation, nausea, vomiting, and abdominal pain. Neurological side effects may include dizziness, drowsiness, headache, insomnia, confusion, and hallucinations occasionally reported, especially in older adults or those with impaired kidney function. Myalgia or arthralgia may occur and, rarely, serious muscle damage such as rhabdomyolysis may occur, so consult a physician immediately if any problems arise. Skin changes such as rashes, alopecia, or itching may occur, so notify someone if any skin changes happen. This medication requires regular monitoring of liver function, kidney function, and blood test values while closely observing therapeutic effect and side effects. Older adults, patients with chronic lung disease, diabetes, and those with weakened immune systems may be at higher risk for pneumonia and need to be monitored closely. This medication can interact with other drugs, so be sure to inform about any medications currently being taken, especially when taking anticoagulants, frequent checks of coagulation status are necessary. Women who are pregnant or may become pregnant and those who are breastfeeding should consult a physician before using this medication, considering the potential effects on the fetus or infant. Safety in children has not been sufficiently established, so caution should be exercised when used in pediatric patients. In case of overdose, appropriate emergency measures such as vomiting or gastric lavage should be taken, and if necessary, dialysis may be performed to remove the medication. When administered via injection, pain or induration at the injection site may occur, and in patients concerned about abnormal heart rates, it should be infused slowly. This medication may mask symptoms of gastric cancer, so patients with gastric ulcers or new or changed digestive symptoms in middle-aged and older patients should confirm malignancy before use. Long-term use may affect ocular tissues, so eye examinations should be conducted cautiously.

Side effects

  • Anaphylaxis shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • vascular edema
  • granulocytopenia
Show 60 more
  • elevation of serum creatinine levels
  • leukopenia
  • thrombocytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic bone marrow
  • hypoplastic anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • generalized malaise
  • weakness
  • subcutaneous mucosal bleeding
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • cardiac arrest
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness of the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurry vision
  • involuntary movement disorders
  • consciousness disorders
  • liver-type muscle spasms
  • gynecomastia
  • excessive lactation
  • erectile dysfunction
  • decreased libido
  • joint pain
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • skin itching
  • acute interstitial nephritis
  • injection site pain
  • injection site induration

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a closed container that blocks light and should preferably be kept at room temperature. Therefore, it should be protected from direct sunlight and stored at a safe temperature away from extreme heat or cold.

Appearance and packaging

Appearance

A colorless to yellowish transparent solution or a brown ampoule form.

Package unit

1 ampoule (4 mL) × 50

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.